New CDC findings highlight the hidden dangers of antihistamines for users who have concomitant exposure to opioids.

Clinicians treating patients with COVID-19  who are at risk for progression to acute disease should be aware of potential drug–drug interactions when the oral antiviral treatment nirmatrelvir/ritonavir (Paxlovid—Pfizer) is administered to people taking common cardiovascular drugs, experts warn in a new Journal of the American College of Cardiology article.

A recent survey from the Institute for Safe Medication Practices (ISMP) puts the pharmacist’s role during code situations into focus.

Compared with more than 3 million unexposed pregnancies, antidepressant-exposed pregnancies could not be directly correlated to a higher risk of autism spectrum disorder, ADHD, learning or developmental speech/language disorders, developmental coordination disorder, intellectual disability, or behavioral disorders, according to new research published in JAMA Internal Medicine.

The Michigan Department of Licensing and Regulatory Affairs (LARA) has released a new interpretation of the Michigan Public Health Code to enable pharmacists to partner with physicians so that the pharmacists directly dispense hormonal birth control.